default author photo

Mar Masiá

Universidad Miguel Hernández de Elche

Avenida de la Universidad s/n

Elche, Alicante 03202

Spain

SCHOLARLY PAPERS

3

DOWNLOADS

226

TOTAL CITATIONS

4

Scholarly Papers (3)

1.

First Evidence of Microplastics Isolated in Lower Airway of European Citizens

Number of pages: 34 Posted: 27 Apr 2022
affiliation not provided to SSRN, affiliation not provided to SSRN, Universidad Autónoma de Madrid, affiliation not provided to SSRN, affiliation not provided to SSRN, Universidad Miguel Hernández de Elche, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 88 (753,595)
Citation 4

Abstract:

Loading...

Airborne microplastics, Airborne microfibers, Bronchoalveolar lavage fluid, Human lung, Human lower airway.

2.

Switch to Dolutegravir/Rilpivirine in Virologically Suppressed, Antiretroviral Treatment-Experienced HIV-1 Infected Individuals with K103N Mutation: 48-Week Results of a Randomised, Pilot Clinical Trial

Number of pages: 23 Posted: 11 May 2023
Government of the United Kingdom - Chelsea and Westminster Hospital NHS Foundation Trust, Sorbonne University - Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Université de Paris Cité - AP-HP, King’s College Hospital NHS Foundation Trust, Hospital Universitari Vall d’Hebron, University of Milan - DIBIC “Luigi Sacco”, Université Libre de Bruxelles (ULB) - CHU Saint-Pierre, Goethe University Frankfurt - University Hospital Frankfurt, Centre Hospitalier Universitaire de Nantes, Government of the United Kingdom - Royal Free London NHS Foundation Trust, Universidad Miguel Hernández de Elche, University of Sussex - Brighton and Sussex Medical School, ViiV Healthcare Ltd., GSK plc, Research Organisation (KC) LTD, Research Organisation (KC) LTD, Research Organisation (KC) LTD, Government of the United Kingdom - Chelsea and Westminster Hospital NHS Foundation Trust and Independent
Downloads 71 (875,328)

Abstract:

Loading...

dolutegravir/rilpivirine, switch, virological suppression, adverse event, K103N mutation

3.

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naïve Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

Number of pages: 28 Posted: 27 May 2021
University Hospital of Bellvitge, Hospital Universitario La Paz, University Hospital of Bellvitge, Hospital General Universitario de Alicante, Hospital de la Santa Creu i Sant Pau - Infectious Diseases Unit, Hospital Germans Trias i Pujol, Hospital Vall d’Hebron, Universidad de Alcalá, IRYCIS - Department of Infectious Diseases, Alvaro Cunqueiro University Hospital, Universidad Miguel Hernández de Elche, Hospital Universitario Virgen de la Victoria, Hospital Universitari Son Espases, Hospital Universitario Son Llatzer, University of Barcelona - Department of Infectious Diseases, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación, Sanitaria del Hospital Clínico San Carlos (IdISSC), Instituto de Salud Carlos III - CIBER de Enfermedades Infecciosas (CIBERINFEC), Complejo Hospitalario Universitario de Badajoz, Hospital Universitario Reina Sofía, Hospital Universitario San Cecilio de Granada - Unidad de Gestión Clínica de Enfermedades Infecciosas, Hospital del Mar - Department of Infectious Diseases, Hospital infanta Leonor, Hospital Universitario Virgen de Valme, Hospital Universitario y Politecnico La Fe, Hospital de la Princesa, University Hospital of Bellvitge, Red de Investigación en Sida, University Hospital of Bellvitge, Universidad de Barcelona - Hospital Clínic Barcelona and Universidad de Alcalá, IRYCIS
Downloads 67 (907,769)

Abstract:

Loading...

darunavir/cobicistat, dolutegravir, tenofovir alafenamide, naive patients, weight